Polynovo

Polynovo ROCE

The Return on Capital Employed (ROCE) of Polynovo (PNV.AX) as of Oct 28, 2026 is 12.41 %. In the previous year, Return on Capital Employed (ROCE) was 9.31 % — a change of 33.20% (higher).

ROCE

12.41 %

YoY

33.20%

Last updated:

In 2026, Polynovo's return on capital employed (ROCE) was 12.41 %, a 33.20% increase from the 9.31 % ROCE in the previous year.

The Polynovo ROCE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROCE
Date
ROCE
Jan 1, 2019
-23.61 AUD
Jan 1, 2020
-17.39 AUD
Jan 1, 2021
-31.12 AUD
Jan 1, 2022
-1.45 AUD
Jan 1, 2023
-9.46 AUD
Jan 1, 2024
1.61 AUD
Jan 1, 2025
9.31 AUD
Jan 1, 2026
12.41 AUD
The Polynovo ROCE history
YEARROCEYoY
12.41 %+33.20%
9.31 %+477.61%
1.61 %-117.05%
-9.46 %+552.05%
-1.45 %-95.34%
-31.12 %+79.02%
-17.39 %-26.36%
-23.61 %-5.22%
-24.91 %-47.65%
-47.58 %+64.43%
-28.94 %-46.10%
-53.68 %+13.08%
-47.47 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Polynovo Stock analysis

What does Polynovo do? Polynovo Ltd is an Australian BioTech company that specializes in the development and manufacturing of medical implants. The company was founded in 1986 under the name Regeneus Ltd and is headquartered in Melbourne. Polynovo's history began with the development of products for the veterinary field. In 2000, the company received approval for the sale of its first human products, which were used for wound treatment. In 2014, the company was renamed Polynovo to emphasize its focus on biological implants for human tissue. Polynovo utilizes a revolutionary technology called NovoSorb, which allows for the production of biodegradable polymer films in various shapes and sizes. These are then used as implants in the human body and naturally degrade within a predetermined timeframe. Polynovo is divided into various divisions, including wound care, plastic surgery, and orthopedics. In wound care, the company offers products that aim to prevent infections and promote natural healing processes. The plastic surgery division provides implants for breast reconstruction and fat transplantation. In orthopedics, Polynovo manufactures implants for joints, bones, and tendons. An example of a Polynovo product is NovoSorb BTM (Biodegradable Temporary Matrix), which is used in burns and other skin defects. The matrix stimulates healing and the formation of new tissue, restoring a normal appearance to the patient. Polynovo's business model is based on long-term relationships with hospitals, medical professionals, and government agencies. The company heavily invests in research and development to continuously improve and expand its technology and product range. Through partnerships with other companies and academic institutions, Polynovo is working towards global distribution of its products. Overall, Polynovo has received various awards over the years, including an innovation award from the Australian Trade Commission, and has been recognized multiple times as one of Australia's fastest-growing companies. In conclusion, Polynovo is an innovative and successful company specializing in the development and manufacturing of biological implants. Thanks to its NovoSorb technology, the company can offer products that help accelerate the healing process and facilitate faster patient recovery. Polynovo is one of the most popular companies on Eulerpool.

ROCE Details

Unraveling Polynovo's Return on Capital Employed (ROCE)

Polynovo's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Polynovo's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Polynovo's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Polynovo’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Polynovo stock

Return on Capital Employed (ROCE) of Polynovo is 12.41 % in 2026.

Return on Capital Employed (ROCE) of Polynovo changed from 9.31 % to 12.41 %, representing a 33.20% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Capital Employed (ROCE) Polynovo since 2006 – with annual values, charts, and detailed analysis.

ROCE is a profitability measure and stands for Return on Capital Employed or the return on invested capital. The measure shows the ratio of operating profit to the interest-bearing capital employed. The higher the return on capital employed, the more profitable a company operates and the higher the important free cash flow. The free cash flow refers to the portion of profits that is not needed for expanding the company at the end of a period, but is available to shareholders.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Capital Employed (ROCE)'s Polynovo with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Capital Employed (ROCE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Capital Employed (ROCE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Polynovo

All Key Metrics — Polynovo